 |
|
|
Quick Help |
 |
|
 |
|
Services |
 |
|
 |
|
 |
Queries |
 |
Tel1: +91 79 65123395 |
Tel2: +91 79 26463395 |
Email: click here |
 |
|
 |
 |
 |
|
 |
|
Aliskiren hemifumarate |
Aliskiren is a first in class non peptide potent renin inhibitor which was approved by the U.S. Food and Drug Administration in 2007 for the treatment of hypertension.
|
Product Reference ID: MA- ZO-1023-O |
 |
|
Chemical Name: |
(2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]-octanamide hemifumarate |
|
 |
Description |
CAS number |
173334-58-2, 173334-57-1, base |
Synonym |
(2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]-octanamide hemifumarate |
Molecular Formula |
C30H53N3O6 • 0.5 C4H4O4 |
Molecular Weight |
609.8, free base - 551.8 |
Application |
For treatment of hypertension |
Material Safety Data Sheet
|
Can be made available on request
|
Availability |
Under R&D |
Comments |
The product is under RND however intermediates can be made available |
|
 |
|
 |
 |
Are you looking for Aliskiren hemifumarate Intermediates ? Please click here to browse through the list of Aliskiren hemifumarate Intermediates available with us. |
 |
Aliskiren, Aliskiren hemifumarate, Aliskiren Fumarate, 173334-58-2, 173334-57-1, Suppliers, manufacturers, India, China |
|
|
|
|
 |
NOTE:
- Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|